Introduction
Abbexa is an international company headquartered in Cambridge (UK), with further locations in Houston (USA) and Leiden (NL). We are a supplier of biological tools for the life science, pharmaceutical development and biotechnology sectors. We provide the scientific community with primary antibodies, secondary antibodies, proteins, ELISA kits and enzymes as well as other kits and tools for use in research.
As a biotechnology company working to supply laboratories for the advancement of research and science, we are keen to ensure that we keep our environmental impact as low as possible. We believe responsible sourcing and provision of goods and services allows us to continue on our path to sustainable growth.
This statement is made pursuant to the Sustainable Development Goals by the United Nations.
‘The Sustainable Development Goals are a call for action by all countries – poor, rich and middle-income – to promote prosperity while protecting the planet. They recognize that ending poverty must go hand-in-hand with strategies that build economic growth and address a range of social needs including education, health, social protection, and job opportunities, while tackling climate change and environmental protection.’
Our Policies and Training
All our employees are required to read and comply with the company's Environmental and Sustainability Policy document and Waste Management Policy document.
All our employees have a responsibility for implementing the Environmental and Sustainability Policy document in their areas of control and are encouraged to submit ideas and comments to help improve sustainable growth.
Our commitment to Sustainability for 2025
The reduce our impact, we will:
1. Reduce CO2 footprint from business-related transport and energy consumption
2. Reduce waste
3. Reduce water and food waste
4. Ensuring sustainable, efficient and responsible procurement, direct activities and supply of all goods and services
This statement has been approved by the board of directors of the Company, with respect to the financial year ending on the 30th of April 2026.
Sabrina Preston
Director
April 2025